+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Infection Surveillance Solutions Market by Software (Cloud-based), Service (Product Support, Maintenance, Implementation), End-user (Hospitals (Large, Medium-Sized, Small Hospitals) Long-Term Care Facilities), COVID-19 Impact - Forecast to 2026

  • ID: 5440131
  • Report
  • September 2021
  • Region: Global
  • 244 Pages
  • Markets and Markets
Global Infection Surveillance Solutions Market is Forecast to Reach $1.03 Billion by 2026, Rising at a CAGR of 15.2%

FEATURED COMPANIES

  • Asolva Inc.
  • Cerner Corporation
  • GOJO Industries, Inc.
  • Medexter Healthcare GmbH
  • Premier, Inc.
  • Stanley Healthcare
  • MORE

The global infection surveillance solutions market is projected to reach USD 1,033 million by 2026 from USD 508 million in 2021, at a CAGR of 15.2%.

The growth in this market can primarily be attributed to the increasing incidence of HAIs and increasing surgical procedures. The rising healthcare expenditure, an increasing number of surgeries, the growing geriatric population, and the increasing incidence of chronic diseases are the other factors driving the growth of this market. Currently, with the surge in COVID-19 cases, there is an increased focus on personal hygiene, coupled with the need to track and monitor the spread of COVID-19 infection.

However, the high installation costs of infection surveillance solution platforms and the reluctance of healthcare professionals to adopt advanced healthcare IT solutions are expected to limit the growth of this market to a certain extent.

Based on the products and services, the software segment accounted for the largest share during the forecast period

Based on product the infection surveillance solutions market is segmented into infection surveillance software solutions and infection surveillance services. The infection surveillance software segment accounted for the largest share of the infection surveillance solutions market. The large share of this segment can be attributed to the increasing need for preventing HAIs and the growing number of surgical procedures leading to surgical site infections. 

Based on the software segment, on-premise software accounted for the largest share during the forecast period

Based on type, the infection surveillance software market is segmented into on-premise and web-based software. The on-premise software segment accounted for the largest share of the infection surveillance software market in 2020. The large share of this segment is mainly attributed to the need for maintaining access to healthcare IT solutions and reduce the risk of data breaches & external attacks.

Based on services, product support and maintenance segment accounted for the largest share during the forecast period

Based on type, the infection surveillance services market is segmented into product support and maintenance services, training and consulting services, and implementation services. The product support and maintenance services segment accounted for the largest share of the infection surveillance services market. Product support and maintenance services take care of interoperability and software complexity issues. These services ensure that clients (healthcare providers) obtain access to the vendor company’s technical knowledge base, gain support from its product support team, and acquire application management skills. These factors are driving the growth of the product support and maintenance services segment.

Based on end-user segment, hospitals accounted for the largest share during the forecast period

Based on end-user, the infection surveillance solutions market is segmented into hospitals, long-term care facilities, and other end users. In 2020, the hospitals segment accounted for the largest share of the infection surveillance solutions market. The large share of this segment can be attributed to the large patient volume, the increasing incidence of HAIs, and the increasing cases of SSIs. The COVID-19 pandemic has also increased the adoption of infection surveillance solutions in hospitals.

North America accounted for the largest share in the infection surveillance solutions market during the forecast period

In 2020, North America accounted for the largest share of the infection surveillance solutions market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this region can be attributed to factors such as the growing consolidation among healthcare providers, widespread adoption of healthcare IT solutions to curtail the rising healthcare costs, increasing incidence of HAIs, and the rising number of COVID-19 patients in the US.

Research Coverage

The report analyzes the infection surveillance solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as products & services, end user, and region. The report also includes a product portfolio matrix of various infection surveillance solutions products & services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Key Players

The key players operating in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier International, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Sunquest (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), IBM Corporation (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab Inc. (US), Harris Healthcare (US), PeraHealth Inc. (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and Vizzia Technologies (US).

Break of primary participants was as mentioned below:

  • By Company Type: Tier 1 - 35%, Tier 2 - 45%, and Tier 3 - 20%
  • By Designation: C-level - 35%, Director-level - 25%, and Others - 40%
  • By Region: North America - 45%, Europe - 30%, Asia-Pacific - 20%, Latin America - 3%, and Middle East & Africa - 2%

Reasons to Buy the Report 

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global infection surveillance solutions market. The report analyzes this market by products & services and end-user.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global infection surveillance solutions market
  • Market Development: Comprehensive information on the lucrative emerging markets by products & services and end user
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global infection surveillance solutions market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global infection surveillance solutions market.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Asolva Inc.
  • Cerner Corporation
  • GOJO Industries, Inc.
  • Medexter Healthcare GmbH
  • Premier, Inc.
  • Stanley Healthcare
  • MORE
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition & Scope
1.2.1 Inclusions & Exclusions of the Study
1.2.2 Market Segmentation
Figure 1 Infection Surveillance Solutions Market Segmentation
1.2.3 Years Considered for the Study
1.3 Currency
Table 1 Exchange Rates Utilized for Conversion to USD
1.4 Stakeholders
1.5 Summary of Changes
2 Research Methodology
2.1 Research Approach
2.2 Research Methodology Design
Figure 2 Infection Surveillance Solutions Market: Research Design
2.2.1 Secondary Research
2.2.1.1 Key Data from Secondary Sources
2.2.2 Primary Data
Figure 3 Primary Sources
2.2.2.1 Key Data from Primary Sources
2.2.2.2 Insights from Primary Experts
Figure 4 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
Figure 5 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.3 Market Size Estimation: Infection Surveillance Solutions Market
Figure 6 Market Size Estimation: Revenue Share Analysis
Figure 7 Revenue Share Analysis Illustration
Figure 8 CAGR Projections from the Analysis of Drivers, Restraints, Opportunities, and Challenges
Figure 9 CAGR Projections
Figure 10 Top-Down Approach
2.4 Data Triangulation Approach
Figure 11 Data Triangulation Methodology
2.5 Market Ranking Estimation
2.6 Assumptions for the Study
2.7 Limitations
2.7.1 Methodology-Related Limitations
2.7.2 Scope-Related Limitations
2.8 Risk Assessment
Table 2 Risk Assessment: Infection Surveillance Solutions Market
3 Executive Summary
Figure 12 Infection Surveillance Solutions Market, by Product & Service, 2021 vs. 2026 (USD Million)
Figure 13 Infection Surveillance Software Market, by Type, 2021 vs. 2026 (USD Million)
Figure 14 Infection Surveillance Services Market, by Type, 2021 vs. 2026 (USD Million)
Figure 15 Infection Surveillance Solutions Market, by End-user, 2021 vs. 2026 (USD Million)
Figure 16 Geographical Snapshot of the Infection Surveillance Solutions Market
4 Premium Insights
4.1 Infection Surveillance Solutions Market Overview
Figure 17 Growing Incidence of Hospital-Acquired Infections to Drive Market Growth
4.2 North America: Infection Surveillance Software Market, by Type and Country
Figure 18 On-Premise Software Segment Accounted for the Largest Share of the North American Market in 2020
4.3 Infection Surveillance Solutions Market: Geographic Growth Opportunities
Figure 19 China to Register the Highest Revenue Growth During the Forecast Period
4.4 Infection Surveillance Solutions Market, by Region (2019-2026)
Figure 20 North America Will Continue to Dominate the Infection Surveillance Solutions Market During the Forecast Period
4.5 Infection Surveillance Solutions Market: Developed vs. Developing Markets
Figure 21 Developing Markets to Register a Higher Growth Rate During the Forecast Period
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Table 3 Market Dynamics: Infection Surveillance Solutions Market
5.2.1 Market Drivers
5.2.1.1 Growing Global Prevalence of COVID-19
Table 4 Total Number of Confirmed COVID-19 Cases, by Region (As of August 23, 2021)
5.2.1.2 Increasing Prevalence of Hospital-Acquired Infections
5.2.1.3 Increasing Adoption of Antimicrobial Stewardship Programs
5.2.1.4 Increasing Number of Surgeries
Table 5 US: Percentage Increase in the Number of Surgeries Performed
5.2.1.5 Growing Geriatric Population and the Increasing Incidence of Chronic Diseases
5.2.1.6 Growing Investments to Improve Healthcare Systems
5.2.2 Market Restraints
5.2.2.1 High Cost of Deployment for Small Healthcare Organizations
Table 6 Average Selling Price of Healthcare IT Solutions, by Product, 2020
5.2.2.2 Reluctance Among Medical Professionals to Adopt Advanced Healthcare IT Solutions
5.2.3 Market Opportunities
5.2.3.1 Increasing Consolidation in the Healthcare Industry
Figure 22 US: Hospital Mergers & Acquisitions, 2015-2019
5.2.3.2 Cloud-based Software Solutions
5.2.3.3 Emerging Markets
5.2.4 Market Challenges
5.2.4.1 Shortage of Skilled Healthcare It Professionals
5.2.4.2 Data Security Concerns
6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Shift Toward Web-based Solutions
6.2.2 Ai-Powered Surveillance Software
6.2.3 Shift Toward Automation in Healthcare Facilities
6.2.4 Infection Surveillance Using Mobile Application Tools
6.3 Regulatory Analysis
6.3.1 North America
6.3.2 Europe
6.3.3 Asia
6.3.4 Middle East and Africa
6.3.5 Latin America
Table 7 Key Regulations & Standards Governing Infection Surveillance Solutions
6.4 Technology Analysis
6.4.1 Cloud Computing Technology
6.4.2 Artificial Intelligence
Table 8 AI in Healthcare Market, by Region, 2017-2026 (USD Million)
6.4.3 Bluetooth Low Energy Sensors
6.5 Ecosystem Analysis
6.5.1 Healthcare IT Market: Ecosystem Analysis
6.5.2 Infection Surveillance Solutions Market: Ecosystem Analysis
6.6 Patent Analysis
6.6.1 Patent Publication Trends for Infection Surveillance Solutions
Figure 23 Patent Publication Trends (January 2011-August 2021)
6.6.2 Jurisdiction and Top Applicant Analysis
Figure 24 Top Applicants & Owners (Companies/Institutions) for Infection Surveillance Solutions Patents (January 2011-August 2021)
Figure 25 Top Applicant Countries/Regions for Infection Surveillance Solutions Patents (January 2011-August 2021)
Table 9 List of Patents/Patent Applications in the Infection Surveillance Solutions Market, 2020-2021
6.7 Impact of COVID-19 on the Infection Surveillance Solutions Market
7 Infection Surveillance Solutions Market, by Product & Service
7.1 Introduction
Table 10 Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
7.2 Software
Figure 26 Infection Surveillance Software Market, by Type, 2021-2026 (USD Million)
Table 11 Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 12 Infection Surveillance Software Market, by Country, 2019-2026 (USD Million)
7.2.1 On-Premise Software
7.2.1.1 Data Protection and In-House Access to Healthcare It Solutions to Drive the Growth of this Market Segment
Table 13 On-Premise Software Solutions Offered by Key Market Players
Table 14 On-Premise Infection Surveillance Software Market, by Country, 2019-2026 (USD Million)
7.2.2 Web-based Software
7.2.2.1 Increasing Demand for Data Centralization and Cost-Benefits of These Solutions to Drive Their Adoption
Table 15 Web-based Software Offered by Key Market Players
Table 16 Web-based Infection Surveillance Software Market, by Country, 2019-2026 (USD Million)
7.3 Infection Surveillance Services
Figure 27 Infection Surveillance Services Market, by Type, 2021-2026 (USD Million)
Table 17 Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 18 Infection Surveillance Services Market, by Country, 2019-2026 (USD Million)
7.3.1 Product Support and Maintenance Services
7.3.1.1 Growing Trend of Outsourcing for Healthcare It Support to Drive the Growth of this Market Segment
Table 19 Product Support & Maintenance Services Market, by Country, 2019-2026 (USD Million)
7.3.2 Implementation Services
7.3.2.1 The Need for Regulatory Compliance to Abide by Relevant Healthcare IT Laws and Regulations to Boost the Growth of this Market Segment
Table 20 Implementation Services Market, by Country, 2019-2026 (USD Million)
7.3.3 Training & Consulting Services
7.3.3.1 These Services Help End-users Enhance Their Understanding of Systems and Software Solutions
Table 21 Training & Consulting Services Market, by Country, 2019-2026 (USD Million)
8 Infection Surveillance Solutions Market, by End-user
8.1 Introduction
Table 22 Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
8.2 Hospitals
Table 23 Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 24 Infection Surveillance Solutions Market for Hospitals, by Country, 2019-2026 (USD Million)
8.2.1 Large Hospitals
8.2.1.1 Growing Need to Deploy Cloud-based Solutions to Drive the Growth of this Market Segment
Table 25 Infection Surveillance Solutions Market for Large Hospitals, by Country, 2019-2026 (USD Million)
8.2.2 Medium-Sized Hospitals
8.2.2.1 Increasing Demand for More Specialized and Advanced Care to Boost the Growth of this Market Segment
Table 26 Infection Surveillance Solutions Market for Medium-Sized Hospitals, by Country, 2019-2026 (USD Million)
8.2.3 Small Hospitals
8.2.3.1 Growing Need to Decrease Operational Costs and Increasing Market Competition to Drive the Growth of this Market Segment
Table 27 Infection Surveillance Solutions Market for Small Hospitals, by Country, 2019-2026 (USD Million)
8.3 Long-Term Care Facilities
Table 28 Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
Table 29 Infection Surveillance Solutions Market for Long-Term Care Facilities, by Country, 2019-2026 (USD Million)
8.3.1 Nursing Homes
8.3.1.1 Growing Geriatric Population to Drive the Growth of this Market Segment
Table 30 Infection Surveillance Solutions Market for Nursing Homes, by Country, 2019-2026 (USD Million)
8.3.2 Skilled Nursing Facilities
8.3.2.1 Advancements in Healthcare It Solutions to Drive the Growth of this Market Segment
Table 31 Infection Surveillance Solutions Market for Skilled Nursing Facilities, by Country, 2019-2026 (USD Million)
8.3.3 Assisted Living Facilities
8.3.3.1 Growing Geriatric Population and the Increasing Need for Quality Care to Drive the Growth of this Market Segment
Table 32 Infection Surveillance Solutions Market for Assisted Living Facilities, by Country, 2019-2026 (USD Million)
8.4 Other End-users
Figure 28 US: Surgical Procedural Volume, by Setting: Ambulatory Surgery Centers vs. Hospitals (2005-2020)
Table 33 Infection Surveillance Solutions Market for Other End-users, by Country, 2019-2026 (USD Million)
9 Infection Surveillance Solutions Market, by Region
9.1 Introduction
Figure 29 Infection Surveillance Solutions Market: Geographic Snapshot (2021-2026)
Table 34 Infection Surveillance Solutions Market, by Region, 2019-2026 (USD Million)
9.2 Impact of COVID-19 on the Infection Surveillance Solutions Market, by Country/Region
9.3 North America
Figure 30 North America: Infection Surveillance Solutions Market Snapshot
Table 35 North America: Infection Surveillance Solutions Market, by Country, 2019-2026 (USD Million)
Table 36 North America: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 37 North America: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 38 North America: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 39 North America: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 40 North America: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 41 North America: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.3.1 US
9.3.1.1 Advanced Medical Infrastructure and Increasing Healthcare Expenditure to Drive the Market Growth
Table 42 US: Key Macroindicators
Table 43 US: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 44 US: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 45 US: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 46 US: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 47 US: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 48 US: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.3.2 Canada
9.3.2.1 Growing Adoption of Technologically Advanced HCIT Solutions to Propel Market Growth in Canada
Table 49 Canada: Key Macroindicators
Table 50 Canada: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 51 Canada: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 52 Canada: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 53 Canada: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 54 Canada: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 55 Canada: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.4 Europe
Table 56 Europe: Infection Surveillance Solutions Market, by Country, 2019-2026 (USD Million)
Table 57 Europe: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 58 Europe: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 59 Europe: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 60 Europe: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 61 Europe: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 62 Europe: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.4.1 Germany
9.4.1.1 Increasing Healthcare Expenditure and Growing Adoption of Healthcare It Solutions to Drive Market Growth in Germany
Table 63 Germany: Key Macroindicators
Table 64 Germany: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 65 Germany: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 66 Germany: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 67 Germany: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 68 Germany: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 69 Germany: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.4.2 France
9.4.2.1 High Healthcare Spending and Favorable Government Initiatives to Drive Market Growth in France
Table 70 France: Key Macroindicators
Table 71 France: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 72 France: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 73 France: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 74 France: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 75 France: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 76 France: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.4.3 UK
9.4.3.1 Rising Number of Surgeries and Implementation of Favorable Government Initiatives to Drive Market Growth in the UK
Table 77 UK: Key Macroindicators
Table 78 UK: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 79 UK: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 80 UK: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 81 UK: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 82 UK: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 83 UK: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.4.4 Italy
9.4.4.1 Increasing Adoption of e-Health Technologies to Propel Market Growth in Italy
Table 84 Italy: Key Macroindicators
Table 85 Italy: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 86 Italy: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 87 Italy: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 88 Italy: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 89 Italy: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 90 Italy: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.4.5 Spain
9.4.5.1 Increasing Focus on Improving the Healthcare Infrastructure and Growing Number of COVID-19 Cases to Support the Market Growth
Table 91 Spain: Key Macroindicators
Table 92 Spain: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 93 Spain: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 94 Spain: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 95 Spain: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 96 Spain: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 97 Spain: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.4.6 Switzerland
9.4.6.1 Increasing Demand for Healthcare Services and Growing Healthcare Awareness to Drive Market Growth
Table 98 Switzerland: Key Macroindicators
Table 99 Switzerland: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 100 Switzerland: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 101 Switzerland: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 102 Switzerland: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 103 Switzerland: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 104 Switzerland: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.4.7 Netherlands
9.4.7.1 Increasing Healthcare Initiatives to Drive Market Growth in the Netherlands
Table 105 Netherlands: Key Macroindicators
Table 106 Netherlands: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 107 Netherlands: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 108 Netherlands: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 109 Netherlands: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 110 Netherlands: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 111 Netherlands: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.4.8 Rest of Europe
Table 112 RoE: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 113 RoE: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 114 RoE: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 115 RoE: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 116 RoE: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 117 RoE: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.5 Asia-Pacific
Figure 31 Asia-Pacific: Infection Surveillance Solutions Market Snapshot
Table 118 Asia-Pacific: Infection Surveillance Solutions Market, by Country, 2019-2026 (USD Million)
Table 119 Asia-Pacific: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 120 Asia-Pacific: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 121 Asia-Pacific: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 122 Asia-Pacific: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 123 Asia-Pacific: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 124 Asia-Pacific: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.5.1 Japan
9.5.1.1 Increasing Geriatric Population to Drive Market Growth in Japan
Table 125 Japan: Key Macroindicators
Table 126 Japan: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 127 Japan: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 128 Japan: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 129 Japan: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 130 Japan: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 131 Japan: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.5.2 China
9.5.2.1 Healthcare Infrastructure Improvements in China to Drive the Market Growth
Table 132 China: Key Macroindicators
Table 133 China: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 134 China: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 135 China: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 136 China: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 137 China: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 138 China: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.5.3 India
9.5.3.1 Increasing Demand for Healthcare It Solutions to Drive Market Growth in India
Table 139 India: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 140 India: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 141 India: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 142 India: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 143 India: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 144 India: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.5.4 Australia and New Zealand
9.5.4.1 Increasing Number of Hospitalizations and Government Initiatives for Infection Prevention to Drive Market Growth in ANZ
Table 145 Australia & New Zealand: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 146 Australia & New Zealand: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 147 Australia & New Zealand: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 148 Australia & New Zealand: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 149 Australia & New Zealand: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 150 Australia & New Zealand: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.5.5 South Korea
9.5.5.1 Increasing Medical Tourism to Drive Market Growth in South Korea
Table 151 South Korea: Key Macroindicators
Table 152 South Korea: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 153 South Korea: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 154 South Korea: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 155 South Korea: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 156 South Korea: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 157 South Korea: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.5.6 Rest of Asia-Pacific
Table 158 RoAPAC: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 159 RoAPAC: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 160 RoAPAC: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 161 RoAPAC: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 162 RoAPAC: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 163 RoAPAC: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.6 Latin America
9.6.1 Healthcare It Initiatives to Drive Market Growth in the Region
Table 164 Latin America: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 165 Latin America: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 166 Latin America: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 167 Latin America: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 168 Latin America: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 169 Latin America: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
9.7 Middle East & Africa
9.7.1 Improving Healthcare Infrastructure and Focus on Safety Measures to Drive Market Growth
Table 170 Middle East & Africa: Infection Surveillance Solutions Market, by Product & Service, 2019-2026 (USD Million)
Table 171 Middle East & Africa: Infection Surveillance Software Market, by Type, 2019-2026 (USD Million)
Table 172 Middle East & Africa: Infection Surveillance Services Market, by Type, 2019-2026 (USD Million)
Table 173 Middle East & Africa: Infection Surveillance Solutions Market, by End-user, 2019-2026 (USD Million)
Table 174 Middle East & Africa: Infection Surveillance Solutions Market for Hospitals, by Type, 2019-2026 (USD Million)
Table 175 Middle East & Africa: Infection Surveillance Solutions Market for Long-Term Care Facilities, by Type, 2019-2026 (USD Million)
10 Competitive Landscape
10.1 Overview
10.2 Key Player Strategies/Right to Win
10.2.1 Overview of Strategies Adopted by Players in the Infection Surveillance Solutions Market
10.3 Adoption Trends for Innovative Solutions
10.4 Revenue Share Analysis of the Top Market Players
Figure 32 Revenue Analysis of Key Players in the Infection Surveillance Solutions Market
10.5 Market Ranking Analysis
Table 176 Infection Surveillance Solutions Market Ranking Analysis, 2020
10.6 Competitive Benchmarking
Table 177 Footprint of Companies in the Infection Surveillance Solutions Market
Table 178 Product & Service Footprint of Companies (20 Companies)
Table 179 End-user Footprint of Companies (20 Companies)
Table 180 Regional Footprint of Companies (20 Companies)
10.7 Competitive Leadership Mapping
10.7.1 Stars
10.7.2 Emerging Leaders
10.7.3 Pervasive Players
10.7.4 Participants
Figure 33 Infection Surveillance Solutions Market: Competitive Leadership Mapping (2020)
10.8 Competitive Leadership Mapping for Other Companies
10.8.1 Progressive Companies
10.8.2 Dynamic Companies
10.8.3 Starting Blocks
10.8.4 Responsive Companies
Figure 34 Infection Surveillance Solutions Market: Competitive Leadership Mapping for Other Companies (2020)
10.9 Competitive Scenario
10.9.1 Product/Service Launches & Approvals
Table 181 Product/Service Launches/Approvals/Enhancements, 2018-2021
10.9.2 Deals
Table 182 Deals, 2018-2021
10.9.3 Other Developments
Table 183 Other Developments, 2018-2021
11 Company Profiles
11.1 Key Players
(Business Overview, Products & Services, Key Insights, Recent Developments, Analyst's View)*
11.1.1 Becton, Dickinson and Company
Table 184 Becton, Dickinson and Company: Business Overview
Figure 35 Becton, Dickinson and Company: Company Snapshot (2020)
11.1.2 Cerner Corporation
Table 185 Cerner Corporation: Business Overview
Figure 36 Cerner Corporation: Company Snapshot (2020)
11.1.3 Premier, Inc.
Table 186 Premier, Inc.: Business Overview
Figure 37 Premier, Inc.: Company Snapshot (2021)
11.1.4 IBM Corporation
Table 187 IBM Corporation: Business Overview
Figure 38 IBM Corporation: Company Snapshot (2020)
11.1.5 Baxter International Inc.
Table 188 Baxter International Inc.: Business Overview
Figure 39 Baxter International Inc.: Company Snapshot (2020)
11.1.6 Gojo Industries, Inc.
Table 189 Gojo Industries, Inc.: Business Overview
11.1.7 RLDatix
Table 190 RLDatix: Business Overview
11.1.8 Wolters Kluwer N.V.
Table 191 Wolters Kluwer N.V.: Business Overview
Figure 40 Wolters Kluwer N.V.: Company Snapshot (2020)
11.1.9 Vigilanz Corporation
Table 192 Vigilanz Corporation: Business Overview
11.1.10 Deb Group Ltd. (Subsidiary of S.C. Johnson & Son, Inc.)
Table 193 Deb Group Ltd.: Business Overview
11.1.11 Sunquest Information Systems (Subsidiary of Roper Tech.)
Table 194 Sunquest Information Systems: Business Overview
11.1.12 Biovigil Healthcare Systems Inc.
Table 195 Biovigil Healthcare Systems Inc.: Business Overview
11.1.13 Ecolab Inc.
Table 196 Ecolab Inc.: Business Overview
Figure 41 Ecolab Inc.: Company Snapshot (2020)
11.1.14 Vecna Technologies
Table 197 Vecna Technologies: Business Overview
11.1.15 bioMérieux SA (Subsidiary of Institut Merieux & Sofina)
Table 198 bioMérieux SA: Business Overview
Figure 42 bioMérieux SA: Company Snapshot (2020)
11.1.16 Harris Healthcare Group (Subsidiary of N. Harris Computer Corporation)
Table 199 Harris Healthcare Group: Business Overview
11.1.17 Perahealth Inc.
Table 200 Perahealth Inc.: Business Overview
11.1.18 Medexter Healthcare GmbH
Table 201 Medexter Healthcare GmbH: Business Overview
11.1.19 Centrak, Inc. (Subsidiary of Halma plc)
Table 202 Centrak, Inc.: Business Overview
11.1.20 CKM Healthcare Incorporated
Table 203 CKM Healthcare Incorporated: Business Overview
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, Analyst's View Might Not be Captured in Case of Unlisted Companies
11.2 Other Players
11.2.1 Asolva Inc.: Company Overview
11.2.2 Pointclickcare: Company Overview
11.2.3 Stanley Healthcare: Company Overview
11.2.4 Vitalacy, Inc.: Company Overview
11.2.5 Vizzia Technologies: Company Overview
12 Appendix
12.1 Insights from Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: The Subscription Portal
12.4 Available Customizations
Note: Product cover images may vary from those shown
  • Asolva Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA (Subsidiary of Institut Merieux & Sofina)
  • BioVigil Healthcare Systems Inc.
  • CenTrak, Inc. (Subsidiary of Halma plc)
  • Cerner Corporation
  • CKM Healthcare Incorporated
  • Deb Group Ltd. (Subsidiary of S.C. Johnson & Son, Inc.)
  • Ecolab Inc.
  • GOJO Industries, Inc.
  • Harris Healthcare Group (Subsidiary of N. Harris Computer Corporation)
  • IBM Corporation
  • Medexter Healthcare GmbH
  • PeraHealth Inc.
  • PointClickCare: Company Overview
  • Premier, Inc.
  • RLDatix
  • Stanley Healthcare
  • Sunquest Information Systems (Subsidiary of Roper Tech.)
  • Vecna Technologies
  • VigiLanz Corporation
  • Vitalacy, Inc.
  • Vizzia Technologies
  • Wolters Kluwer N.V.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll